首页> 外文期刊>International Journal of Pharmaceutics >Electrospun diclofenac sodium loaded Eudragit(R) L 100-55 nanofibers for colon-targeted drug delivery.
【24h】

Electrospun diclofenac sodium loaded Eudragit(R) L 100-55 nanofibers for colon-targeted drug delivery.

机译:静电纺丝的双氯芬酸钠L 100-55纳米纤维负载于结肠靶向药物递送。

获取原文
获取原文并翻译 | 示例
           

摘要

Eudragit(R) L 100-55 nanofibers loaded with diclofenac sodium (DS) were successfully prepared using an electrospinning process, and characterized for structural and pharmacodynamic properties. The influence of solvent and drug content on fiber formation and quality was also investigated. Fiber formation was successful using a solvent mixture 5:1 (v/v) ethanol:DMAc. XRD and DSC analysis of fibers confirm electron microscopic evidence that DS is evenly distributed in the nanofibers in an amorphous state. FTIR analysis indicates hydrogen bonding occurs between the drug and the polymer, which accounts for the molecular integration of the two components. In vitro dissolution tests verified that all the drug-loaded Eudragit(R) L 100-55 nanofibers had pH-dependent drug release profiles, with limited, less than 3%, release at pH 1.0, but a sustained and complete release at pH 6.8. This profile of properties indicates drug-loaded Eudragit(R) L 100-55 nanofibers have the potential to be developed as oral colon-targeted drug delivery systems.
机译:负载双氯芬酸钠(DS)的Eudragit L 100-55纳米纤维已使用静电纺丝工艺成功制备,并对其结构和药效特性进行了表征。还研究了溶剂和药物含量对纤维形成和质量的影响。使用5:1(v / v)乙醇:DMAc的溶剂混合物成功形成纤维。纤维的XRD和DSC分析证实了电子显微镜证据,即DS以无定形状态均匀分布在纳米纤维中。 FTIR分析表明在药物和聚合物之间发生氢键,这说明了这两种成分的分子结合。体外溶出度测试证实,所有载有药物的Eudragit L 100-55纳米纤维均具有pH依赖性药物释放曲线,在pH 1.0时具有有限的释放,少于3%,但在pH 6.8时可以持续完全释放。 。该特性曲线表明载有药物的Eudragit L 100-55纳米纤维具有开发为靶向结肠的口服药物传递系统的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号